Mon. 22 Apr 2024, 5:12pm ET
Benzinga
Earnings, Earnings Beats, News
Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.10) by 60 percent. This is a 78.95 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $17.58 million which beat the analyst consensus estimate of $11.54 million by 52.37 percent. This is a 72.06 percent increase over sales of $10.22 million the same period last year.